The results showed that CKMT2 was involved in tumor immunomodulatory pathways, especially the adaptive immune system, innate immune system, complement activation alternative pathway, and immunomodulatory interaction of immunoglobulin (Fig. 10A–F). This evidence concerns the gene CKMT2 and neoplasm.